Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sprint Bioscience AB | 520,000 | net | 31 May 2024 | tx 2+520,000 |
| Eros Capital Partners AB | 23,750 | net | 01 Dec 2025 | tx 1+23,750 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Dec 2025 | PURCHASE | Eros Capital Partners AB | 23,750 | 1.64 SEK | first after silence |
| 31 May 2024 | GRANT_AWARD | Sprint Bioscience AB | 500,000 | 0.12 SEK | deriv |
| 22 Dec 2023 | PURCHASE | Sprint Bioscience AB | 20,000 | 1.29 SEK |
1 purchase reported after at least 12 months of silence — most recent on 01 Dec 2025.